Eva Y Pan, Diana M Sobieraj. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Administration, OralAnticoagulants/administration & dosageAnticoagulants/adverse effectsAnticoagulants/pharmacokineticsDabigatran/administration & dosageDabigatran/adverse effectsDabigatran/pharmacokineticsDrug InteractionsHumansOutpatientsPyrazoles/administration & dosagePyrazoles/adverse effectsPyrazoles/pharmacokineticsPyridines/administration & dosagePyridines/adverse effectsPyridines/pharmacokineticsPyridones/administration & dosagePyridones/adverse effectsPyridones/pharmacokineticsRenal Insufficiency, Chronic/drug therapyRivaroxaban/administration & dosageRivaroxaban/adverse effectsRivaroxaban/pharmacokineticsThiazoles/administration & dosageThiazoles/adverse effectsThiazoles/pharmacokineticsVenous Thromboembolism/drug therapy
Substances： See more » AnticoagulantsPyrazolesPyridinesPyridonesThiazolesapixabanRivaroxabanDabigatranedoxaban
Year: 2016 PMID： 27024982
Source DB: PubMed Journal: Conn Med ISSN： 0010-6178